These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6874110)

  • 1. [Kinetics and distribution of 206Bi in the rat and the rabbit: a model].
    Vienet R; Bouvet P; Istin M
    Int J Appl Radiat Isot; 1983 Apr; 34(4):747-53. PubMed ID: 6874110
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic studies with radiobismuth. I. Retention and distribution of 206Bi in the normal rat.
    Russ GA; Bigler RE; Tilbury RS; Woodard HQ; Laughlin JS
    Radiat Res; 1975 Sep; 63(3):443-54. PubMed ID: 1162032
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue and subcellular distribution of bismuth radiotracer in the rat: considerations of cytotoxicity and microdosimetry for bismuth radiopharmaceuticals.
    Zidenberg-Cherr S; Parks NJ; Keen CL
    Radiat Res; 1987 Jul; 111(1):119-29. PubMed ID: 3602349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fecal and urinary elimination of bismuth after parenteral administration. (author's transl)].
    Chaleil D; Allain P; Emile J
    Pathol Biol (Paris); 1979 Sep; 27(7):417-20. PubMed ID: 388321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 205Bi/206Bi cyclotron production from Pb-isotopes for absorption studies in humans.
    Fischer R; Wendel J; Dresow B; Bechtold V; Heinrich HC
    Appl Radiat Isot; 1993 Dec; 44(12):1467-72. PubMed ID: 8257965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of oral administration of bismuth subnitrate on distribution and excretion of intraperitoneally given radiobismuth in rats (author's transl)].
    Chaleil D; Allain P
    Ann Pharm Fr; 1979; 37(7-8):285-90. PubMed ID: 539736
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue distribution of 212Bi in rats.
    Hursh JB; Brown C
    Proc Soc Exp Biol Med; 1969 May; 131(1):116-20. PubMed ID: 5770083
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain and blood levels of bismuth after oral or parenteral administration of tripotassium-dicitrato bismuthate to rats.
    Abbracchio MP; Balduini W; Cavallaro A; Adamoli P; Fittipaldi M; Muzio F; Malandrino S; Cattabeni F
    Neurotoxicology; 1985; 6(3):139-43. PubMed ID: 4047510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved in vivo stability and tumor targeting of bismuth-labeled antibody.
    Ruegg CL; Anderson-Berg WT; Brechbiel MW; Mirzadeh S; Gansow OA; Strand M
    Cancer Res; 1990 Jul; 50(14):4221-6. PubMed ID: 2364380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term retention of 207Bi in the human body after injection of 206Bi.
    Buijs WC; Corstens FH; Beentjes LB
    Health Phys; 1985 Dec; 49(6):1267-9. PubMed ID: 4077529
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tissue binding of orally administered bismuth in the rat. Effect of the digestive microbial flora].
    Jeanrot R; Chaleil D; Allain P; Papillon C; Raynaud G; Bouvet P
    Toxicol Eur Res; 1982 Jul; 4(4):181-5. PubMed ID: 7157361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution of orally administered bismuth in the rat.
    Lee SP; Lim TH; Pybus J; Clarke AC
    Clin Exp Pharmacol Physiol; 1980; 7(3):319-24. PubMed ID: 7398137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dosing of bismuth in blood and urine of patients treated for a short time with insoluble bismuth preparations (author's transl)].
    Djudzman R; Van den Eeckhout E; De Moerloose P
    Acta Gastroenterol Belg; 1978; 41(1-2):81-6. PubMed ID: 665115
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetic study of 205-206 Bi-citrate in the rat. Compartmental repartition (author's transl)].
    Pieri F; Wegmann R
    Cell Mol Biol Incl Cyto Enzymol; 1981; 27(1):57-60. PubMed ID: 7237488
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraarterial distribution of colloidal bismuth compounds injected in man.
    Lundell G
    Acta Radiol Ther Phys Biol; 1972 Oct; 11(5):395-400. PubMed ID: 4509862
    [No Abstract]   [Full Text] [Related]  

  • 16. Site of bismuth absorption from bismuth subsalicylate: implications for treatment of colonic conditions.
    Suarez FL; Furne J; Stiehm J; Garten C; Levitt MD
    Dig Dis Sci; 2000 Jul; 45(7):1444-6. PubMed ID: 10961727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kidney uptake of bismuth as an index of its digestive absorption in mice].
    Renault H; Rapin JR; Bralet AM
    C R Acad Hebd Seances Acad Sci D; 1976 Jan; 282(3):325-7. PubMed ID: 816560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent studies of the tumor concentration of radioactive heavy metal isotopes (203Hg, 206Bi and 64Cu)].
    Gerhard H; Mundinger F; Gabriel E; Waldbar H
    Nucl Med (Stuttg); 1965; 2():229-37. PubMed ID: 5888952
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates.
    Milenic DE; Roselli M; Mirzadeh S; Pippin CG; Gansow OA; Colcher D; Brechbiel MW; Schlom J
    Cancer Biother Radiopharm; 2001 Apr; 16(2):133-46. PubMed ID: 11385960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study relating to bioavailability and renal elimination of bismuth after oral administration of basic bismuth nitrate.
    Behrendt WA; Gröger C; Kuhn D; Schulz HU; Topfmeier P
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):357-60. PubMed ID: 1937997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.